Bladder-bowel relief without pills: physiotherapy and exercise put to the test in teens with obesity

NCT ID NCT07724158

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This trial tests whether two non-drug programs—targeted physiotherapy or supervised exercise—can reduce bladder and bowel symptoms in adolescents aged 13–18 with obesity. Participants will be randomly assigned to one of the two interventions or to standard obesity care for 12 weeks. The study aims to see if these approaches improve symptom severity, quality of life, and related health measures.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
target physiotherapy (integrated urotherapy and pelvic floor training) and exercise support (supervised physical exercise and HIIT)
What this could lead to
If effective, these non-drug programs could offer new, accessible ways to manage bladder-bowel symptoms in adolescents with obesity, improving quality of life without medication.
What could go wrong
This is a relatively small, single-center trial. The interventions are behavioral and require commitment, so results may not apply broadly. There is no guarantee either approach will outperform usual care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 237 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jan 2027

An estimate. Start dates often move.

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

13 to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male or female adolescents aged 13 to 18 years. * Obesity defined as BMI z-score ≥2, according to the WHO growth reference for school-aged children and adolescents. * Currently receiving obesity treatment at the Pediatric Outpatient Clinic, Department of Pediatrics, Hospital de Santa Maria, Unidade Local de Saúde de Santa Maria, Lisbon, Portugal. * Able to understand the study procedures and comply with study requirements. * Written informed consent provided by a parent or legal guardian. * Written assent provided by the adolescent. Exclusion Criteria: * Known neurological disorder affecting bladder or bowel function. * Structural urinary tract or gastrointestinal malformation. * Previous pelvic surgery affecting urinary or bowel continence. * Diabetes mellitus or uncontrolled endocrine or monogenic disorders affecting obesity or bladder/bowel function. * Severe psychiatric disorder requiring immediate specialized treatment and likely to interfere with study participation or adherence. * Major orthopedic or musculoskeletal condition preventing safe participation in the exercise intervention. * Current participation in another interventional clinical trial.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bladder-bowel dysfunction are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bowel dysfunction Lower Urinary Tract Symptoms Motor Activity Obesity obesity disorder Overweight Pediatric Obesity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hospital de Santa Maria, ULS SM

    Lisbon, Portugal

More trials for these conditions

Other studies related to the condition(s) this trial covers.